IL-10 and class 1 histone deacetylases act synergistically and independently on the secretion of proinflammatory mediators in alveolar macrophages.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 21 07 2020
accepted: 22 12 2020
entrez: 20 1 2021
pubmed: 21 1 2021
medline: 11 5 2021
Statut: epublish

Résumé

Anti-inflammatory cytokine IL-10 suppresses pro-inflammatory IL-12b expression after Lipopolysaccharide (LPS) stimulation in colonic macrophages, as part of the innate immunity Toll-Like Receptor (TLR)-NF-κB activation system. This homeostatic mechanism limits excess inflammation in the intestinal mucosa, as it constantly interacts with the gut flora. This effect is reversed with Histone Deacetylase 3 (HDAC3), a class I HDAC, siRNA, suggesting it is mediated through HDAC3. Given alveolar macrophages' prominent role in Acute Lung Injury (ALI), we aim to determine whether a similar regulatory mechanism exists in the typically sterile pulmonary microenvironment. Levels of mRNA and protein for IL-10, and IL-12b were determined by qPCR and ELISA/Western Blot respectively in naïve and LPS-stimulated alveolar macrophages. Expression of the NF-κB intermediaries was also similarly assessed. Experiments were repeated with AS101 (an IL-10 protein synthesis inhibitor), MS-275 (a selective class 1 HDAC inhibitor), or both. LPS stimulation upregulated all proinflammatory mediators assayed in this study. In the presence of LPS, inhibition of IL-10 and/or class 1 HDACs resulted in both synergistic and independent effects on these signaling molecules. Quantitative reverse-transcriptase PCR on key components of the TLR4 signaling cascade demonstrated significant diversity in IL-10 and related gene expression in the presence of LPS. Inhibition of IL-10 secretion and/or class 1 HDACs in the presence of LPS independently affected the transcription of MyD88, IRAK1, Rela and the NF-κB p50 subunit. Interestingly, by quantitative ELISA inhibition of IL-10 secretion and/or class 1 HDACs in the presence of LPS independently affected the secretion of not only IL-10, IL-12b, and TNFα, but also proinflammatory mediators CXCL2, IL-6, and MIF. These results suggest that IL-10 and class 1 HDAC activity regulate both independent and synergistic mechanisms of proinflammatory cytokine/chemokine signaling. Alveolar macrophages after inflammatory stimulation upregulate both IL-10 and IL-12b production, in a highly class 1 HDAC-dependent manner. Class 1 HDACs appear to help maintain the balance between the pro- and anti-inflammatory IL-12b and IL-10 respectively. Class 1 HDACs may be considered as targets for the macrophage-initiated pulmonary inflammation in ALI in a preclinical setting.

Identifiants

pubmed: 33471802
doi: 10.1371/journal.pone.0245169
pii: PONE-D-20-22628
pmc: PMC7816993
doi:

Substances chimiques

IL10 protein, mouse 0
Il12b protein, mouse 0
Inflammation Mediators 0
Interleukin-12 Subunit p40 0
Interleukin-10 130068-27-8
Histone Deacetylases EC 3.5.1.98

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0245169

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Virol. 2020 Mar 17;94(7):
pubmed: 31915279
J Immunol. 2000 Jul 1;165(1):292-6
pubmed: 10861064
Nat Med. 2005 Nov;11(11):1173-9
pubmed: 16244651
Blood. 2012 Nov 29;120(23):4653-62
pubmed: 22966168
N Engl J Med. 1987 Dec 17;317(25):1565-70
pubmed: 3317054
J Exp Med. 2008 Oct 27;205(11):2609-21
pubmed: 18838547
J Immunol. 2015 Feb 1;194(3):855-60
pubmed: 25596299
Immunol Rev. 2007 Dec;220:60-81
pubmed: 17979840
Signal Transduct Target Ther. 2017;2:
pubmed: 29158945
BMC Bioinformatics. 2017 Nov 29;18(1):529
pubmed: 29187165
Biochem Pharmacol. 2006 Nov 30;72(11):1423-31
pubmed: 16889755
Immunity. 2001 Jun;14(6):705-14
pubmed: 11420041
EMBO J. 2011 May 18;30(10):1977-89
pubmed: 21468030
Am J Respir Crit Care Med. 2008 Jul 1;178(1):34-41
pubmed: 18403723
Nat Rev Immunol. 2010 Mar;10(3):170-81
pubmed: 20154735
Biochem Pharmacol. 2005 Aug 1;70(3):394-406
pubmed: 15950952
Immunol Rev. 2008 Dec;226:205-18
pubmed: 19161426
Blood. 2000 May 15;95(10):3183-90
pubmed: 10807786
Infect Immun. 2001 Sep;69(9):5249-63
pubmed: 11500393
JAMA. 2016 Feb 23;315(8):788-800
pubmed: 26903337
J Biol Chem. 2006 Feb 17;281(7):4540-7
pubmed: 16371367
Vaccines (Basel). 2017 Oct 04;5(4):
pubmed: 28976923
J Biol Chem. 2002 Mar 15;277(11):9590-7
pubmed: 11777905
N Engl J Med. 2014 Jun 5;370(23):2191-200
pubmed: 24835849
Blood Cells Mol Dis. 1999 Oct-Dec;25(5-6):328-38
pubmed: 10660480
Nat Immunol. 2011 Jul 19;12(8):689-94
pubmed: 21772277
J Interferon Cytokine Res. 2007 Jun;27(6):453-62
pubmed: 17572009
JCI Insight. 2019 Aug 22;4(16):
pubmed: 31434802
J Immunol. 1998 Jun 15;160(12):5936-44
pubmed: 9637507
Crit Rev Immunol. 2012;32(1):23-63
pubmed: 22428854
Trends Immunol. 2019 May;40(5):447-462
pubmed: 30962001
J Immunol. 2010 Aug 1;185(3):1894-902
pubmed: 20610652
Infect Immun. 2005 Mar;73(3):1754-63
pubmed: 15731076
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
J Exp Med. 2005 Oct 17;202(8):1131-9
pubmed: 16230478
Immunol Rev. 2004 Dec;202:96-105
pubmed: 15546388
Science. 1993 Apr 23;260(5107):547-9
pubmed: 8097338
Science. 2001 Aug 31;293(5535):1653-7
pubmed: 11533489
Genes Dev. 2007 Jul 15;21(14):1790-802
pubmed: 17639084
Cell Immunol. 1997 Mar 15;176(2):180-5
pubmed: 9073392
Respir Res. 2007 Oct 04;8:71
pubmed: 17916230
Eur J Immunol. 2005 Oct;35(10):2991-3001
pubmed: 16184516
Cell Signal. 2013 May;25(5):1228-34
pubmed: 23422584
Aging Cell. 2020 Apr;19(4):e13130
pubmed: 32170906
N Engl J Med. 2005 Oct 20;353(16):1685-93
pubmed: 16236739
Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12617-22
pubmed: 20616024
Nat Immunol. 2012 Jul 19;13(8):722-8
pubmed: 22814351
N Engl J Med. 2006 Apr 20;354(16):1671-84
pubmed: 16625008
J Immunol. 2012 Aug 15;189(4):1792-9
pubmed: 22786766
J Exp Med. 1994 Jun 1;179(6):1895-902
pubmed: 8195715
Mol Cell Biol. 2001 Oct;21(20):7065-77
pubmed: 11564889
J Immunol. 2000 Jun 1;164(11):5564-74
pubmed: 10820230
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5761-6
pubmed: 19307576
FASEB J. 2018 Oct;32(10):5312-5325
pubmed: 29718706
Nat Genet. 2000 Jun;25(2):187-91
pubmed: 10835634
J Immunol. 2007 Jan 15;178(2):1164-71
pubmed: 17202381
Curr Biol. 2011 Jul 12;21(13):R488-93
pubmed: 21741580
PLoS One. 2012;7(2):e31080
pubmed: 22347433
F1000Res. 2015 Dec 17;4:
pubmed: 26918147
J Immunol. 1999 Apr 1;162(7):3749-52
pubmed: 10201887
JAMA. 2016 Jun 14;315(22):2406-14
pubmed: 27179988
J Neuroimmunol. 1995 Jul;60(1-2):165-8
pubmed: 7642744
J Trauma Acute Care Surg. 2018 Jul;85(1):148-154
pubmed: 29958249
Nature. 2001 Dec 20-27;414(6866):920-4
pubmed: 11780066
N Engl J Med. 2014 Oct 30;371(18):1695-703
pubmed: 25268516
Genes Dev. 2018 Oct 1;32(19-20):1309-1314
pubmed: 30228203

Auteurs

Brent A Stanfield (BA)

Duke University Medical Center, Durham, North Carolina, United States of America.
Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.
Division of Trauma, Acute and Critical Care Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.

Todd Purves (T)

Duke University Medical Center, Durham, North Carolina, United States of America.
Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.
Division of Urology, Duke University Medical Center, Durham, North Carolina, United States of America.

Scott Palmer (S)

Duke University Medical Center, Durham, North Carolina, United States of America.
Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Duke Clinical Research Institute, Durham, North Carolina, United States of America.

Bruce Sullenger (B)

Duke University Medical Center, Durham, North Carolina, United States of America.
Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.

Karen Welty-Wolf (K)

Duke University Medical Center, Durham, North Carolina, United States of America.
Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.

Krista Haines (K)

Duke University Medical Center, Durham, North Carolina, United States of America.
Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.
Division of Trauma, Acute and Critical Care Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.

Suresh Agarwal (S)

Duke University Medical Center, Durham, North Carolina, United States of America.
Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.
Division of Trauma, Acute and Critical Care Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.

George Kasotakis (G)

Duke University Medical Center, Durham, North Carolina, United States of America.
Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.
Division of Trauma, Acute and Critical Care Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH